Annual non current assets:
$444.33M+$95.25M(+27.29%)Summary
- As of today (May 29, 2025), ARWR annual long term assets is $444.33 million, with the most recent change of +$95.25 million (+27.29%) on September 30, 2024.
- During the last 3 years, ARWR annual non current assets has risen by +$118.78 million (+36.49%).
- ARWR annual non current assets is now at all-time high.
Performance
ARWR Non current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly non current assets:
$438.28M-$4.88M(-1.10%)Summary
- As of today (May 29, 2025), ARWR quarterly long term assets is $438.28 million, with the most recent change of -$4.88 million (-1.10%) on March 31, 2025.
- Over the past year, ARWR quarterly non current assets has increased by +$24.78 million (+5.99%).
- ARWR quarterly non current assets is now -1.36% below its all-time high of $444.33 million, reached on September 30, 2024.
Performance
ARWR quarterly non current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Non current assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
ARWR Non current assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.3% | +6.0% |
| 3 y3 years | +36.5% | +53.3% |
| 5 y5 years | +425.2% | +77.7% |
ARWR Non current assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +55.0% | -1.4% | +53.3% |
| 5 y | 5-year | at high | +425.2% | -1.4% | +157.8% |
| alltime | all time | at high | >+9999.0% | -1.4% | >+9999.0% |
ARWR Non current assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $438.28M(-1.1%) |
| Dec 2024 | - | $443.16M(-0.3%) |
| Sep 2024 | $695.47M(+67.0%) | $444.33M(+2.5%) |
| Jun 2024 | - | $433.70M(+4.9%) |
| Mar 2024 | - | $413.50M(+6.5%) |
| Dec 2023 | - | $388.39M(+11.3%) |
| Sep 2023 | $416.47M(+2.8%) | $349.08M(+7.2%) |
| Jun 2023 | - | $325.69M(+2.9%) |
| Mar 2023 | - | $316.50M(+0.0%) |
| Dec 2022 | - | $316.49M(+10.4%) |
| Sep 2022 | $405.30M(+5.4%) | $286.64M(-10.3%) |
| Jun 2022 | - | $319.39M(+11.7%) |
| Mar 2022 | - | $285.94M(-4.8%) |
| Dec 2021 | - | $300.26M(-7.8%) |
| Sep 2021 | $384.60M(+19.3%) | $325.55M(+55.8%) |
| Jun 2021 | - | $208.97M(+22.9%) |
| Mar 2021 | - | $170.04M(-3.1%) |
| Dec 2020 | - | $175.53M(-12.3%) |
| Sep 2020 | $322.37M(+21.5%) | $200.13M(-16.8%) |
| Jun 2020 | - | $240.50M(-2.5%) |
| Mar 2020 | - | $246.60M(+208.3%) |
| Dec 2019 | - | $79.99M(-5.5%) |
| Sep 2019 | $265.25M(+236.7%) | $84.60M(-8.3%) |
| Jun 2019 | - | $92.29M(-6.7%) |
| Mar 2019 | - | $98.97M(+7.6%) |
| Dec 2018 | - | $92.00M(+180.1%) |
| Sep 2018 | $78.77M(+16.0%) | $32.84M(-35.6%) |
| Jun 2018 | - | $51.03M(+48.6%) |
| Mar 2018 | - | $34.34M(-2.2%) |
| Dec 2017 | - | $35.11M(-2.8%) |
| Sep 2017 | $67.90M(-25.0%) | $36.12M(-2.9%) |
| Jun 2017 | - | $37.18M(-0.0%) |
| Mar 2017 | - | $37.18M(-2.2%) |
| Dec 2016 | - | $38.03M(+0.9%) |
| Sep 2016 | $90.50M(-12.0%) | $37.67M(+4.8%) |
| Jun 2016 | - | $35.93M(+26.2%) |
| Mar 2016 | - | $28.46M(-2.2%) |
| Dec 2015 | - | $29.10M(-1.0%) |
| Sep 2015 | $102.87M(-33.5%) | $29.40M(-3.6%) |
| Jun 2015 | - | $30.50M(-27.8%) |
| Mar 2015 | - | $42.23M(+40.9%) |
| Dec 2014 | - | $29.97M(+7.0%) |
| Sep 2014 | $154.80M(+436.7%) | $28.02M(-15.6%) |
| Jun 2014 | - | $33.20M(-18.5%) |
| Mar 2014 | - | $40.72M(+150.1%) |
| Dec 2013 | - | $16.28M(+91.9%) |
| Sep 2013 | $28.84M(+339.2%) | $8.49M(+19.9%) |
| Jun 2013 | - | $7.08M(-18.5%) |
| Mar 2013 | - | $8.68M(-5.3%) |
| Dec 2012 | - | $9.17M(-8.0%) |
| Sep 2012 | $6.57M | $9.96M(-5.9%) |
| Jun 2012 | - | $10.59M(-6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $11.26M(-18.9%) |
| Dec 2011 | - | $13.89M(+130.4%) |
| Sep 2011 | $9.86M(+21.3%) | $6.03M(-3.4%) |
| Jun 2011 | - | $6.24M(-6.2%) |
| Mar 2011 | - | $6.66M(+60.4%) |
| Dec 2010 | - | $4.15M(-1.7%) |
| Sep 2010 | $8.13M(+227.4%) | $4.22M(-5.5%) |
| Jun 2010 | - | $4.47M(-6.2%) |
| Mar 2010 | - | $4.77M(-4.3%) |
| Dec 2009 | - | $4.98M(-4.6%) |
| Sep 2009 | $2.48M(-76.5%) | $5.22M(-4.1%) |
| Jun 2009 | - | $5.44M(-9.1%) |
| Mar 2009 | - | $5.99M(-6.0%) |
| Dec 2008 | - | $6.37M(-4.9%) |
| Sep 2008 | $10.56M(-58.3%) | $6.69M(+46.0%) |
| Jun 2008 | - | $4.58M(+7.2%) |
| Mar 2008 | - | $4.28M(-4.0%) |
| Dec 2007 | - | $4.46M(-2.0%) |
| Sep 2007 | $25.31M(-12.1%) | $4.55M(-1.4%) |
| Jun 2007 | - | $4.61M(+4.5%) |
| Mar 2007 | - | $4.41M(-21.1%) |
| Dec 2006 | - | $5.59M(-2.8%) |
| Sep 2006 | $28.78M(+26.1%) | $5.75M(-37.8%) |
| Jun 2006 | - | $9.24M(+3.0%) |
| Mar 2006 | - | $8.97M(+41.0%) |
| Dec 2005 | - | $6.36M(+2.2%) |
| Sep 2005 | $22.81M(+140.2%) | $6.23M(+23.5%) |
| Jun 2005 | - | $5.04M(+3.8%) |
| Mar 2005 | - | $4.86M(+79.3%) |
| Dec 2004 | - | $2.71M(+12.0%) |
| Sep 2004 | $9.50M(+527.3%) | $2.42M(+99.6%) |
| Jun 2004 | - | $1.21M(>+9900.0%) |
| Mar 2004 | - | $9600.00(+433.3%) |
| Dec 2003 | - | $1800.00(-10.0%) |
| Sep 2003 | $1.51M(+4616.2%) | $2000.00(-92.4%) |
| Jun 2003 | - | $26.30K(-6.1%) |
| Mar 2003 | - | $28.00K(-5.7%) |
| Dec 2002 | - | $29.70K(-5.4%) |
| Sep 2002 | $32.10K(-30.1%) | $31.40K(-11.3%) |
| Jun 2002 | - | $35.40K(+1670.0%) |
| Mar 2002 | - | $2000.00(+400.0%) |
| Dec 2001 | - | $400.00(0.0%) |
| Sep 2001 | $45.90K(+185.1%) | $400.00(>+9900.0%) |
| Jun 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(-100.0%) |
| Dec 2000 | - | $46.70K(-4.9%) |
| Sep 2000 | $16.10K(-38.8%) | $49.10K(-2.8%) |
| Jun 2000 | - | $50.50K(-4.0%) |
| Mar 2000 | - | $52.60K(-3.7%) |
| Dec 1999 | - | $54.60K |
| Sep 1999 | $26.30K(+19.5%) | - |
| Sep 1998 | $22.00K(-35.5%) | - |
| Sep 1997 | $34.10K | - |
FAQ
- What is Arrowhead Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual non current assets year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly non current assets year-on-year change?
What is Arrowhead Pharmaceuticals annual long term assets?
The current annual non current assets of ARWR is $444.33M
What is the all time high annual non current assets for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual long term assets is $444.33M
What is Arrowhead Pharmaceuticals annual non current assets year-on-year change?
Over the past year, ARWR annual long term assets has changed by +$95.25M (+27.29%)
What is Arrowhead Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of ARWR is $438.28M
What is the all time high quarterly non current assets for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly long term assets is $444.33M
What is Arrowhead Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, ARWR quarterly long term assets has changed by +$24.78M (+5.99%)